Indian Journal of Dermatology
E-IJDŽ-REVIEW ARTICLE
Year
: 2022  |  Volume : 67  |  Issue : 4  |  Page : 479-

A joint consensus of rheumatologists and dermatologists on early detection and effective management of psoriatic arthritis: India's perspective


Manas Chatterjee1, Chitra Nayak2, Abhishek De3, Samir Rajadhyaksha4, GK Singh5, Phani Kumar6, S Balameena7, M Harish Kumar8, M Hema9, Gautam Dhar Choudhury10, Ghan Shyam Pangtey11, Jatinder Singh12, Neeraj Jain13 
1 From the Command Hospital, Kolkata, West Bengal, India
2 Nair Hospital, Mumbai, Maharashtra, India
3 Calcutta National Medical College, Kolkata, West Bengal, India
4 Global Hospital, Parel, Mumbai, Maharashtra, India
5 Base Hospital, Delhi, India
6 NIMS, Hyderabad, Telangana, India
7 Department of Rheumatology, Kilpauk Medical College, Chennai, Tamil Nadu, India
8 Department of Rheumatology, Command Hospital, Bangalore, Karnataka, India
9 Department of Rheumatology, Stanley Medical College, Chennai, Tamil Nadu, India
10 Department of Rheumatology and Clinical Immunology, Command Hospital (Eastern Command), Alipore Road, Kolkata, West Bengal, India
11 LHMC, Delhi, India
12 AFMC, Pune, Maharashtra, India
13 Sir Ganga Ram Hospital, Delhi, India

Correspondence Address:
Abhishek De
Calcutta National Medical College, Kolkata, West Bengal
India

Psoriatic arthritis (PsA) is a chronic inflammatory disease with clinical manifestations, including inflammatory arthritis and the presence of psoriasis (PsO). The present consensus statement evaluated the early diagnosis and treatment approaches in the management of psoriasis and psoriatic arthritis by rheumatologists and dermatologists. For PAN India representation, a panel of eight rheumatologists and five dermatologists from different institutes in India were constituted. These thirteen experts were divided into two groups (rheumatologists group and dermatologist group) who received a set of questionnaires each for diagnosis and treatment approaches in the management of psoriasis and psoriatic arthritis. Based on the responses received, a panel discussion took place, where the experts identified the early diagnostic criteria for PsA considering: Clinical signs and symptoms, and questionnaire-based PsA screening, which includes Psoriasis Epidemiology Screening Tool (PEST) for dermatologists and Classification Criteria for Psoriatic Arthritis (CASPAR) for rheumatologists. The experts also recommended shift from conventional disease-modifying anti-rheumatic drugs (DMARDs) to biologics like secukinumab, when there is extensive skin involvement and TNF inhibitors when there is extensive joint involvement. Overall, the objective of the consensus was to assist rheumatologists and dermatologists in the early diagnosis and management of patients of PsA and PsO in their clinical practice.


How to cite this article:
Chatterjee M, Nayak C, De A, Rajadhyaksha S, Singh G K, Kumar P, Balameena S, Kumar M H, Hema M, Choudhury GD, Pangtey GS, Singh J, Jain N. A joint consensus of rheumatologists and dermatologists on early detection and effective management of psoriatic arthritis: India's perspective.Indian J Dermatol 2022;67:479-479


How to cite this URL:
Chatterjee M, Nayak C, De A, Rajadhyaksha S, Singh G K, Kumar P, Balameena S, Kumar M H, Hema M, Choudhury GD, Pangtey GS, Singh J, Jain N. A joint consensus of rheumatologists and dermatologists on early detection and effective management of psoriatic arthritis: India's perspective. Indian J Dermatol [serial online] 2022 [cited 2023 Feb 6 ];67:479-479
Available from: https://www.e-ijd.org/article.asp?issn=0019-5154;year=2022;volume=67;issue=4;spage=479;epage=479;aulast=Chatterjee;type=0